No Contract Terminations. Except as otherwise disclosed in the Registration Statement or the Prospectus, neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, or any document incorporated by reference therein, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company’s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 2 contracts
Sources: Open Market Sale Agreement (Arrowhead Pharmaceuticals, Inc.), Open Market Sale Agreement (Arrowhead Pharmaceuticals, Inc.)
No Contract Terminations. Except as otherwise disclosed in the Registration Statement or the Prospectus, neither Neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in any preliminary prospectus or the Prospectus or any free writing prospectusProspectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, and, except as would not be reasonably expected, individually or any document incorporated by reference thereinin the aggregate, and to result in a Material Adverse Change, no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company’s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 2 contracts
Sources: Underwriting Agreement (Allurion Technologies, Inc.), Underwriting Agreement (Allurion Technologies, Inc.)
No Contract Terminations. Except as otherwise disclosed in the Registration Statement or the Prospectus, neither Neither the Company nor any of its subsidiaries and consolidated affiliated entities has sent or received any communication regarding termination of, or intent not to renew, any of the material contracts or agreements referred to or described in any preliminary prospectus, the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement or the F-6 Registration Statement, or any document incorporated by reference therein, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries and consolidated affiliated entities or, to the Company’s knowledge, knowledge any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 1 contract
No Contract Terminations. Except as otherwise disclosed would not reasonably be expected, individually or in the Registration Statement or the Prospectusaggregate, to result in a Material Adverse Change, neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Registration Statement, the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, or any document incorporated by reference therein, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company’s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 1 contract
Sources: Open Market Sale Agreement (SQZ Biotechnologies Co)
No Contract Terminations. Except as otherwise disclosed in the Registration Statement or the Prospectus, neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, or any document incorporated by reference therein, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company’s knowledge, any other party to | any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 1 contract
Sources: Open Market Sale Agreement (Arrowhead Pharmaceuticals, Inc.)
No Contract Terminations. Except as otherwise disclosed in the Registration Statement or the Prospectus, neither Neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the material contracts or agreements referred to or described in the Registration Statement, the Time of Sale Prospectus, the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, or any document incorporated by reference therein, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company’s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 1 contract
No Contract Terminations. Except as otherwise disclosed in the Registration Statement or the Prospectus, neither Neither the Company nor any of its subsidiaries has sent or received any communication regarding termination of, or intent not to renew, any of the contracts or agreements referred to or described in the Prospectus or any free writing prospectus, or referred to or described in, or filed as an exhibit to, the Registration Statement, or any document incorporated by reference thereintherein that would either individually or in the aggregate constitute a Material Adverse Change, and no such termination or non-renewal has been threatened by the Company or any of its subsidiaries or, to the Company’s knowledge, any other party to any such contract or agreement, which threat of termination or non-renewal has not been rescinded as of the date hereof.
Appears in 1 contract
Sources: Open Market Sale Agreement (Mesa Laboratories Inc /Co/)